Show simple item record

dc.contributor.authorGlobal Communications Director
dc.contributor.editorNtonjira, Elizabeth
dc.date.accessioned2021-10-26T12:20:53Z
dc.date.available2021-10-26T12:20:53Z
dc.date.issued2020
dc.identifier.urihttps://repository.amref.ac.ke/handle/123456789/293
dc.description.abstractMalaria still, severely, impacts life and health in Africa and remains one of the continent’s biggest killers. It is estimated that four out of 10 pregnant women are exposed to the malaria parasite, leading to maternal deaths, underweight children, and potential lifelong disabilities. These may have contributed to the death of more than 250,000 children under the age of five in Africa in 2019. Households sink deeper into poverty as they deal with increased out-of-pocket expenditures in accessing care and treatment. Additionally, modelling studies have shown that COVID-19-related disruptions in access to effective antimalarial treatment are likely to reverse all progress made in reducing morbidity and malarial deaths in Africa.en_US
dc.language.isoenen_US
dc.subjectmalaria vaccineen_US
dc.subjectMosquirixen_US
dc.subjectmorbidity and malarial deaths in Africaen_US
dc.titleClarion Call for Africa to meet at the Middle in the Malaria Vaccine Introductionen_US
dc.typePosition Statementen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record